Bald Ambition

In this 45th episode of Bald Ambition, host Mookie Spitz sits down with attorney–pharmacist Darshan Kulkarni to dissect the fast-growing world of Direct-to-Patient (DTP) marketing and clinical trial models. He unpacks how DTP has evolved, why it appeals to pharmaceutical companies, and—most importantly—the hidden complexities that come with it. 

From state law inconsistencies to privacy, advertising, malpractice, and consent concerns, Darshan shows how what looks like a simple shift to “just using Zoom” quickly becomes a tangled web of compliance obligations. Whether you’re in legal, clinical operations, or marketing, this conversation breaks down the real risks and why they matter for anyone thinking about engaging patients directly.  

Their conversation reveals a system in freefall—chaotic, fragmented, and confusing at every level:

• Telemedicine blurred the boundaries between pharma, providers, and patients, raising questions of responsibility and compliance.
• Competing laws across states leave companies unsure whether they’re in full compliance or skating on thin ice.
• HIPAA, PHI, and data ownership are entangled with marketing funnels, referral pathways, and AI-driven documentation tools.
• PBMs (pharmacy benefit managers) continue to inflate costs while claiming to save money, adding another layer of distortion to the supply chain.
• Patients, providers, pharma, and tech firms are caught in a spaghetti bowl of shifting rules, competing interests, and massive financial incentives.

Darshan lays out clear recommendations for anyone navigating this uncertainty—whether you’re a pharmaceutical company, provider, tech startup, or pharmacy:

• Rethink your business model completely. Don’t assume past practices will hold up.
• Flow-chart every patient touchpoint. Map interactions across providers, pharmacies, telehealth platforms, and pharma.
• Bring legal oversight into the room early. Compliance isn’t an afterthought—it must be baked into design, engineering, and marketing.
• Stay on top of evolving regulations. Monitor FDA, FTC, DOJ, OIG, and state-level changes in real time.
• Balance compliance with patient care. Never lose sight of the ultimate goal: better, safer, more accessible health outcomes.

The Guest

Darshan Kulkarni is a Philadelphia-based food and drug lawyer who focuses on the legal and regulatory challenges of Direct-to-Patient (DTP) programs in pharma and medical devices. As the founder of the Kulkarni Law Firm, he helps companies balance innovation with compliance and addresses issues like privacy, advertising, informed consent, and multi-state telemedicine rules. Darshan also teaches FDA regulatory law and hosts the DarshanTalks podcast, where he breaks down the risks and opportunities of engaging patients directly.

His Firm

The Kulkarni Law Firm is a boutique life sciences law practice based in Philadelphia, dedicated to helping pharmaceutical, biotech, and medical device companies navigate FDA, FTC, and DOJ compliance. The Firm focuses on high-risk areas where law and business intersect—including Direct-to-Patient (DTP) programs, drug and device advertising, clinical research operations, and mergers and acquisitions. By combining regulatory insight with practical industry experience, the Firm supports clients in managing promotional review committees, structuring compliant patient engagement, and preparing for government scrutiny.

Resources

https://www.kulkarnilawfirm.com

https://www.linkedin.com/company/klf-promotions/ 

https://www.darshantalks.com

Send the host a text! Let him know what you think

Support the show

Regulatory turbulence just slammed into the world of direct-to-consumer pharmaceutical advertising. On this 44th episode of Bald Ambition, Mookie Spitz sits down again with Dale Cooke, president of Philly Cooke Consulting and FDA Ad Law, to unpack the latest shockwave: the Make America Healthy Again report and the FDA’s sudden announcement of intensified DTC enforcement.

Topline takeaways for pharma DTC marketers:

• The foundational rules haven’t changed — yet.
• The government has explicitly said they will change, but no timeline or specifics are confirmed.
• Enforcement is already tightening: several warning letters have been issued, but the industry doesn’t know how many, to whom, or what violations were cited.
• Until those letters are made public, marketers are operating in a fog of uncertainty.

From whispered AI-authored warning letters to the looming uncertainty, Mookie and Dale cut through the noise to separate hype from hard reality. Are pharma marketers staring at a return to the scrolling wall of side effects from the 1980s? Will influencer campaigns on social media be the next target? And how the hell do you green-light a new campaign when the rules may change tomorrow morning?

Key Topics:

• FDA’s AI enforcement push – how machine-generated warning letters could reshape compliance overnight.
• “Adequate provision” under fire – what happens if websites and 1-800 numbers no longer satisfy disclosure rules.
• The specter of retro-regulation – could marketers be forced back to interminable scrolling text on TV ads?
• Influencer marketing crackdown – why TikTok and Instagram campaigns may face the harshest scrutiny yet.
• Living with uncertainty – the art of staying compliant when the rules are declared “in flux” but not yet published.
• Strategic survival – how pharma brands can hedge between delay, risk, and costly re-work while keeping campaigns alive.

If you work in pharma, healthcare marketing, or just want to know how billions of ad dollars pivot on bureaucratic whim, this is your must-listen.

The Guest

Dale Cooke is the president of PhillyCooke Consulting and FDA Ad Law. He helps companies communicate about FDA-regulated products using 21st century tools, while remaining compliant with regulations written in the 1960s. Dale has worked with more than 50 pharmaceutical and medical device clients and more than 30 advertising agencies around the world. His insights have been featured in Politico, The Pink Sheet, Stat News, Law360, and others. Dale is an active member of the Food and Drug Law Institute (FDLI), the Alliance for a Stronger FDA, and the Digital Health Coalition.

Dale teaches in the Temple University School of Pharmacy RAQA program, and is the author of Effective Review and Approval of Digital Promotional Tactics, now in its second edition in FDLI’s Topics in Food and Drug Law series. He speaks at industry conferences on topics including FDA enforcement trends, best practices for review processes, global review practices, and life sciences use of social media.

Resources

https://fda.complianceexpert.com/news/FDA-intelligence/continuing-to-innovate-during-regulatory-uncertainty

Dale's LinkedIn Profile

Dale's Blog

Send the host a text! Let him know what you think

Support the show

The 43rd episode of Bald Ambition with Mookie Spitz welcomes Matthew Stern, CEO of MyStart Health, for a deep dive into how technology and entrepreneurship are reshaping healthcare.

We live in an age of disruption—culture, politics, wellness—all shifting under our feet. But while the headlines scream collapse, Stern argues the opposite: technology and medicine are colliding to extend lives, cut costs, and democratize access to care.

Matt shares his journey from 20 years in digital marketing to launching MyStart Health, a telehealth platform that connects patients nationwide to affordable GLP-1 weight-loss treatments. We talk about how his personal experiences—losing his father too young, watching his wife and mother navigate underserved areas of women’s health—inspired him to create solutions that tackle cost, access, and personalization head-on.

The Topics

• The GLP-1 revolution: why drugs like semaglutide and tirzepatide are more than a fad—they’re a catalyst for lasting lifestyle change.
• The insurance gap: how Big Pharma pricing and short-sighted insurers leave patients stranded, and how MyStart fills the void with affordability and speed.
• Women’s health & HRT: the overlooked market, FDA policy shifts, and MyStart’s upcoming “Rise” program to support women in perimenopause and menopause.
• Mental health + physical health: the often-ignored psychological toll of weight loss and how MyStart plans to integrate mental wellness into its platform.
• AI and personalization: not as a robot replacement, but as a way to free doctors from clerical work and restore real human connection.

What emerges is not Chicken Little’s “sky is falling” narrative but an optimistic vision of medicine’s future—where personalization, gratitude, and community drive better outcomes.

If you’ve ever struggled with weight, seen family members sidelined by poor access to care, or wondered what AI means for the doctor-patient relationship, this convo is for you. 

The Guest

Matt Stern’s journey didn’t start in boardrooms — it started with nothing. After experiencing homelessness in his early years, Matt built himself up from the ground floor, eventually creating businesses that have collectively generated over $300 million in sales. But his story isn’t just about business. It’s about resilience, fatherhood, and navigating pressure — the pressure of building success while raising a family. As a dedicated father, Matt speaks openly about the balance between ambition and presence — leading companies while still showing up for the people who matter most. Whether he’s building businesses, raising his kids, or playing 18 holes, Matt’s mission is simple: help people win — in business, in family, and in life.

The Company

MyStart Health is a telehealth provider focusing on improving healthcare through its personalized medical weight loss program. By offering compounded GLP-1 medication, pricing is significantly less expensive compared to name-brand medications like Ozempic, Wegovy, and Zepbound. Woman’s World recently spoke to MyStart’s CEO, Matthew Stern, and its Chief Medical Advisor, Dr. Ritu Chopra, about the very new online prescriber about what sets it apart from other telehealth providers.

The Resources

https://thesterngroup.com

https://www.mystarthealth.com

https://www.washingtonpost.com/health/2025/04/05/ai-machine-learning-radiology-software/

Send the host a text! Let him know what you think

Support the show

The 42nd episode of Bald Ambition doesn't provide the answer to Life, the Universe, and Everything, but does highlight the hypocrisy baked into influencer marketing, media, and public relations. 

Mookie Spitz sits down with Adam Swart, the outspoken founder and CEO of Crowds On Demand. Known for his provocative media appearances and unapologetic takes on modern influence, Swart pulls back the curtain on how public opinion is shaped—not just in boardrooms and newsrooms, but on the streets, in protests, and across every channel where people consume information. Their conversation digs into the mechanics of paid demonstrations, the blurred line between grassroots activism and corporate-backed spectacle, and the fierce reactions Swart provokes from pundits across the political spectrum.

As Swart points out, nearly every article, broadcast, or viral campaign is a form of marketing, yet staged protests are singled out for outrage. From his perspective, there’s little difference between a PR firm planting stories in the New York Times, a network pundit being paid millions to deliver their “independent” take, or an influencer cashing a brand check to post on TikTok. What Crowds On Demand does is simply make that process visible. 

Swart also argues that, by compensating participants—often housekeepers, retail workers, and others who wouldn’t otherwise have the time or flexibility to attend—he is actually democratizing protest. Instead of activism being limited to the wealthy or the privileged with free time, his model allows working-class voices to be represented in the public square. By being explicit about the transactional nature of influence, Swart forces critics to confront the double standard: we accept being sold to everywhere else, but recoil when the same mechanics are applied to public demonstrations.

About Adam Swart
Adam Swart is a political strategist, entrepreneur, and commentator whose work has landed him on Fox News, Newsmax, NewsNation, and even across the table from Chris Cuomo. Since founding Crowds On Demand in 2012, Swart has been at the center of high-stakes campaigns that range from corporate disputes to advocacy movements and headline-grabbing political demonstrations. He’s drawn fire as a so-called “villain of influence,” but he embraces transparency and argues that his work democratizes public expression by opening participation to people who otherwise wouldn’t have a voice.

About Crowds On Demand
Crowds On Demand is a Los Angeles–based publicity and advocacy firm that specializes in organizing live demonstrations, protests, rallies, and influencer-driven events to shape public perception and force issues into the spotlight. The company has executed campaigns across politics, corporate conflicts, and social causes—sometimes tipping the scales of debate when traditional PR avenues fall flat. In this episode, Swart breaks down examples ranging from the “Delete Facebook” campaign to local power-plant battles, showing how his team builds organizations, recruits participants, and sustains visibility until decision-makers are forced to respond.

Adam challenges listeners to reconsider how influence works in 2025, and whether the outrage over “manufactured” protests says more about the messenger than the message. The next time you see or participate in a protest, on either side of the political aisle, consider who organized it—and who paid for it.

How to Contact Adam

https://crowdsondemand.com/contact-us

https://x.com/ceoadamswart

Send the host a text! Let him know what you think

Support the show

Host Mookie Spitz sits down again with Dale Cooke, president of Philly Cooke Consulting and FDA Ad Law, known affectionately as the “Yoda of Compliance.” Together, they unpack the chaos rippling through healthcare communications in the wake of CDC restructuring, FDA shake-ups, and a political climate that has turned vaccines—once celebrated as humanity’s greatest public health achievement—into a weaponized political wedge issue.

Cooke reassures listeners that, for now, “the train is still on the tracks”: the core rules governing FDA promotional enforcement actions haven’t changed, even if the noise around them has reached deafening levels. But reassurance gives way to urgency, as the convo turns to mounting misinformation, the erosion of public trust, and the consequences of government officials openly undermining their own scientific triumphs.

From Operation Warp Speed’s breakthrough mRNA vaccines to George Washington’s variolation orders during the Revolutionary War, the pod cuts through political theater to remind healthcare communicators of their north star: protecting patients and improving lives. Spitz and Cooke challenge the industry to double down on educating and empowering HCPs, and face the stubborn persistence of outdated beliefs like 18th-century vitalism, repackaged in modern anti-vax rhetoric.

Key themes:

• Why FDA enforcement suggests “business as usual” despite political upheaval — at least for now
• How misinformation has shifted from fringe hippie circles to mainstream partisan battles
• Why industry must empower doctors, nurses, and pharmacists as the frontline against falsehoods
• The urgent need for trustworthy sources and resilient communication strategies

The pod is not just another policy convo, but a wake-up call when truth, science, and human lives collide with politics and misinformation. 

The Guest

Dale Cooke is the president of PhillyCooke Consulting and FDA Ad Law. He helps companies communicate about FDA-regulated products using 21st century tools, while remaining compliant with regulations written in the 1960s. Dale has worked with more than 50 pharmaceutical and medical device clients and more than 30 advertising agencies around the world. His insights have been featured in Politico, The Pink Sheet, Stat News, Law360, and others. Dale is an active member of the Food and Drug Law Institute (FDLI), the Alliance for a Stronger FDA, and the Digital Health Coalition.

Dale teaches in the Temple University School of Pharmacy RAQA program, and is the author of Effective Review and Approval of Digital Promotional Tactics, now in its second edition in FDLI’s Topics in Food and Drug Law series. He speaks at industry conferences on topics including FDA enforcement trends, best practices for review processes, global review practices, and life sciences use of social media.

Dale earned his B.A. in Philosophy from Southern Methodist University, an M.A. in Philosophy from the University of Arizona, studied Epidemiology and Biostatistics at Drexel University’s School of Public Health, received a graduate certificate in Healthcare Compliance from Seton Hall University’s School of Law, and his J.D. at Drexel University’s Kline School of Law.

Resources

https://www.buzzsprout.com/2455310/episodes/17081263

https://fda.complianceexpert.com/news/FDA-intelligence/continuing-to-innovate-during-regulatory-uncertainty

https://www.linkedin.com/in/daleacooke/

https://regulatoryrx.blogspot.com/ 

Send the host a text! Let him know what you think

Support the show

Healthcare and pharma agencies face a tough reality: talent is their lifeblood, but also their greatest liability. On this Labor Day 40th edition of Bald Ambition, host Mookie Spitz sits down with Sameer Duhmale and Andre de Luz, co-founders of Talus, to explore why hiring in healthcare marketing is uniquely difficult, and how their platform offers a way forward.

The Challenges

• Niche Expertise 
• Regulatory Burden 
• Global Fragmentation 
• Time Pressure 

The Solution

• Speed — find vetted freelancers in as little as three hours, not three days.
• Scalability — spin up entire teams, from medical writers and designers to account managers and strategists, across all stages of pharma lifecycle projects.
• Locality — access freelancers in seven geographies, ensuring compliance with local regulations and 24/7 global coverage.
• Quality Assurance — every freelancer is screened for years of healthcare communications experience, with detailed profiles, endorsements, and disease-state expertise down to subpopulations and biomarkers.
• AI Integration — Talus GPT-style matching will make nuanced search intuitive, while freelancers receive AI training to stay sharp in an evolving landscape.

The Guests

Sameer Dhumale is the co‑founder of Talus, a platform designed to transform how healthcare and medical communications agencies access freelance expertise. With a background at the intersection of health, technology, and strategy, Sameer brings a sharp focus on building sustainable models that benefit both clients and freelancers. At Talus, he leads on strategic growth, innovation, and client partnerships—ensuring the platform not only solves immediate resourcing challenges but also strengthens the MedComms ecosystem long term. Sameer’s approach combines entrepreneurial drive with an emphasis on collaboration and trust, the values at the heart of Talus.

Andre da Luz is the visionary founder of Talus, a platform revolutionizing how healthcare agencies connect with top-tier freelance talent in medical communications. With a deep understanding of the health communications landscape built from 10 years within OPEN Health, Andre established Talus to address the critical need for flexible, high-quality resourcing solutions. His mission is to empower both agencies and freelancers by fostering a seamless, efficient, and transparent ecosystem. Andre's leadership is driven by a passion for innovation and a commitment to elevating standards within the MedComms industry.

The Company

Talus is a dynamic platform dedicated to seamlessly connecting healthcare and medical communications agencies with elite freelance talent. Born from a deep understanding of the industry's unique demands, Talus addresses the critical need for flexible, high-quality, and specialized expertise. We streamline the entire engagement process, from talent discovery and vetting to project management and payments, ensuring agencies can rapidly scale their teams with confidence and freelancers can access rewarding opportunities. At Talus, we're not just a marketplace; we're building a trusted ecosystem that empowers both sides of the equation, fostering efficiency, transparency, and excellence in health communications.

The Resources

Website: www.talusfreelance.com

Agency sign up link:https://www.talusfreelance.com/agencies/get-started/

Email Andre for more info and support: [email protected] 

Send the host a text! Let him know what you think

Support the show

Marketing savvy, political chaos, and raw philosophy collide here as Mookie Spitz—a bald, blunt veteran of advertising and PR—cuts through the confusion to expose how persuasion really works, and why institutions keep screwing it up.

In this episode, Mookie takes on the CDC, the vaccine wars, and the larger collapse of trust in American public health. He starts with a simple truth he learned in the trenches: you can’t make people do what they don’t want to do. That lesson applies just as much to selling sneakers as it does to selling science. Yet during the pandemic, government agencies tried exactly that: mandates, incomplete-truths, and data dumps delivered to a frightened, skeptical public. The result was predictable: backlash, paranoia, and a communication failure so severe it helped reshape politics, amplify conspiracy theories, and hand the microphone to anti-science voices like RFK Jr.

Mookie isn’t anti-vaccine, far from it. He’s emphatic: vaccines, aside from clean water, have saved more lives than any other medical advancement in history. But the way the government sold the COVID vaccine was a textbook disaster. By downplaying risks, dismissing fears, and burying adverse cases instead of acknowledging them, leaders alienated millions. In marketing, trust is brand identity. Lose that, and you lose your audience. That’s exactly what happened, and we’re still living in the wreckage.

His rant isn’t just about public health. Instead, he pulls the lens back to explore how bad communication drives bigger crises: crime stats that don’t match lived reality, authoritarian leaders exploiting ignored fears, and a science-illiterate public left to navigate mandates it never trusted. Along the way, Mookie brings in philosophy (Feyerabend’s Against Method, Burroughs’ virus-like bureaucracy), politics, and the hard lessons of PR. The takeaway: facts don’t change minds, empathy does. First hearts, then data. Always.

But the news isn't all bad, as he shares a few concrete recommendations: 

Know your audience

• Understand cultural fears, skepticism, and biases. Meet people where they are instead of lecturing from above.

Lead with emotion, not data

• Acknowledge fear and hesitancy first. Facts alone don’t change behavior—empathy does.

Validate lived experience

• Don’t dismiss people’s side effects, fears, or stories. If someone felt sick for two days after a shot, pretending it’s “nothing” destroys trust.

Be transparent about risks and uncertainty

• Admit vaccines can have rare side effects. Admit breakthrough infections happen. If you bury that information, you make it bigger.

Empower choice instead of forcing compliance

• Mandates backfire. People resent being told what to do. Frame decisions as personal agency, not top-down orders.

Communicate benefits as self-flattering

• Show how choosing vaccination (or any behavior) is a reflection of being smart, caring, strong, or community-minded.

Acknowledge the collective fear, not just the individual case

• Don’t just dismiss paranoia—address why people are scared, and connect to the broader reality.

Avoid overreliance on authority or orthodoxy

• Bureaucratic, top-down messaging feels manipulative. Speak like a trusted peer, not an institution.

Rebuild science literacy over the long term

• A deeper problem is the U.S. education system. Without basic science understanding, every communication battle will repeat itself.

Send the host a text! Let him know what you think

Support the show

Former California legislator Mike Gatto sits with host Mookie Spitz for an unflinching look at the collapse of bipartisanship, the failures of political messaging, and the growing civil war inside the Democratic Party.

Gatto reflects on his years in the California Assembly and contrasts that era of rough but workable compromise with today’s toxic climate, where bipartisanship is treated as a relic. He explains why authenticity, not policy papers, drives voter trust—and how Democrats’ overeducated “university speak” and obsession with statistics (like claiming “crime is down 30%”) leave ordinary Americans cold.

The conversation zeroes in on the Democratic split: Gavin Newsom-style centrists who chase swing voters with calculated moderation versus the AOC–Bernie left, convinced that only progressive polarization can match Trump’s movement. This ideological tug-of-war, Gatto argues, is paralyzing the party and preventing real leadership from rising to the surface.

Mookie pushes back with the marketer’s lens: in an attention economy, you can’t ignore Trump—the dominant brand—without becoming invisible. Gatto counters with his belief that Democrats need new products altogether, not just weak imitations of the GOP playbook. Together they debate whether politics today is about policy, platform, or pure personality, and why Democrats keep failing to connect with working-class voters.

The episode doesn’t stop at politics. They dive into the despair of young men, the erosion of economic hope, and the looming disruption of artificial intelligence—an upheaval Gatto compares to past industrial revolutions but with new risks to human intuition and emotional connection. Their conversation is wide-ranging, sharp, and deeply relevant to anyone trying to make sense of where America is heading.

The Guest

Mike Gatto is a former California State Assemblymember who won eight elections to serve four terms, including as Assistant Speaker. In the Legislature he chaired key committees on Appropriations, Consumer Protection & Privacy, and Utilities & Commerce—shaping billions in state spending, advancing technology and cybersecurity policy, and leading landmark reforms in energy and regulation. Over his tenure, fifty-five of his authored measures became law, including California’s first Rainy Day Fund, production tax incentives that kept entertainment jobs in Southern California, reforms to Proposition 65 that curbed abusive lawsuits, $700 million to clean polluted groundwater, and even the revival of the state’s classic black license plates.

Before and after public office, Gatto built a career as an attorney and advisor, practicing at one of Los Angeles’s most prestigious firms and arguing cases all the way to the U.S. Supreme Court. Today he counsels Fortune 500 companies, small businesses, and investors on navigating law, regulation, and politics, while also serving as a trusted commentator on national media. Known for his problem-solving approach and bipartisan record, he blends legal expertise with real-world results.

Follow Mike on X.

https://x.com/mikegatto

Send the host a text! Let him know what you think

Support the show

In today's podcast, Mookie unpacks the parallels between consultative selling and political persuasion. With a marketer’s eye and a content creator’s grind — including his own experiment building 15K+ followers on TikTok — Mookie reveals how narratives spread, how attention is captured, and how messaging succeeds or collapses.

Politics is branding. Campaigns are marketing. And in today’s attention economy, the leaders who master perception win, while those who rely on facts alone lose. Mookie isn’t partisan, and instead exposes flawed Democrat strategy and messaging in this example to dissect persuasion in all its forms — political, commercial, cultural. 

One vivid example: after posting a video on TikTok about his years living in New York City describing encounters with homelessness, an unsafe neighborhood, and even being physically assaulted on the subway, a commenter flatly called him a liar. Why? Because Democratic messaging insists that crime is “down 30%.” The data point was heard as proof that no crime exists, invalidating his real, lived experience. This clash between statistics and emotional truth lies at the heart of branding failure.

The show goes deeper by treating politicians as brands. Just as Apple, Nike, or Tesla position themselves around identity and emotion, so do political leaders. Donald Trump, for example, positioned his “brand” around strength, order, and empathy for his base’s pain points. Democrats, meanwhile, have often undercut their own positioning by relying on statistics that deny or dismiss the lived experiences of their voters. 

The same laws of marketing apply:

• Positioning matters. If you don’t define what you stand for in emotional terms, someone else will define it for you.
• Features don’t sell — feelings do. In politics, touting statistics without addressing pain is like selling a phone by rattling off specs without showing how it makes life better.
• Consistency builds trust. Voters, like consumers, flock to brands that clearly embody their promises and identities, over time and across platforms.

Here's where political analysis blends with lessons in marketing psychology:

• How Trump’s intuitive grasp of brand identity made him a maestro of attention.
• Why Democrats’ reliance on “rational” messaging alienates their own base.
• What marketers and political strategists alike can learn from the emotional resonance of lived experience.
• How ignoring pain points — whether of voters or customers — always backfires.

Whether you’re in marketing, politics, or just trying to understand why narratives matter more than numbers, this podcast reveals the mechanics of influence in a world where perception is reality.

Send the host a text! Let him know what you think

Support the show

In the 36th episode of Bald Ambition, host Mookie Spitz digs into the heart of education with Michelle Waugh—a doctorate-trained scientist who left academia to devote herself to personal tutoring. What makes her story remarkable isn’t just her credentials, but her conviction that personalized learning—built on empathy, patience, and human connection—can succeed where our system repeatedly fails.

Michelle shares how a severely autistic fifth-grader, written off by the public school system as “hopeless,” learned to read Dr. Seuss and Berenstain Bears after just one summer of weekly one-on-one sessions. She explains why phonics works better than memorization, how audiobooks transform reading comprehension, and why even gifted kids need tailored approaches to stay engaged.

Together, Mookie and Michelle explore:

• Personalization over standardization: Why no two students should be taught the same way.
• Empathy and patience as superpowers: The quiet, consistent presence that makes breakthroughs possible.
• Parents as partners: How nightly reading, advocacy in 504 meetings, and active support can change outcomes.
• Technology as a bridge: Audiobooks, text-to-speech, and other tools that complement—not replace—the human touch.

Michelle’s belief in personalization is rooted in her own journey. She holds a PhD in plant pathology—a field she pursued out of fascination with fungi and a desire to teach at the college level. But she left that world behind, disillusioned not just by the limits of research but also by the darker realities of academia. Early in her career, she faced harassment from a senior professor—a classic example of the #MeToo power imbalance in male-dominated sciences. That betrayal of trust drove her to step away from the lab and toward work where she could define her own space and values.

In tutoring, Michelle found what she had always been seeking: the chance to teach in a way that was direct, humane, and impactful. Her story is not only about the victories of her students but also about her own resilience—choosing to create a space where empathy and patience are central, not optional.

The episode is both a celebration of the small miracles that come from personalized instruction and a critique of the larger systems—schools, academia, and culture—that too often crush individuality. It reminds us that education is not mass production, but a deeply human relationship, one child at a time.

If you’ve ever doubted whether a single teacher’s attention can change a child’s life—or whether someone can reclaim their purpose after being failed by institutions—Michelle’s story proves otherwise.

The Guest

Michelle Waugh is a dedicated tutor specializing in supporting students with special needs. With years of hands-on experience, she blends patience, empathy, and proven teaching strategies to help children overcome academic and personal challenges. Michelle works closely with parents, creating individualized plans that not only improve learning outcomes but also build confidence and independence. Her commitment goes beyond academics, as she focuses on nurturing each student’s unique strengths, ensuring they feel understood, supported, and capable of success. Michelle holds a doctorate in biology and a California multiple-subject teaching credential, and brings over 20 years of experience as a teacher, instructional assistant, substitute teacher, and tutor in both in-person and online settings.

Her Website

https://michellewaughtutor.crd.co/

Send the host a text! Let him know what you think

Support the show